Spinnaker Trust Has $4.87 Million Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Spinnaker Trust boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 62,918 shares of the company’s stock after buying an additional 3,489 shares during the quarter. Spinnaker Trust’s holdings in GE HealthCare Technologies were worth $4,865,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of GEHC. Chicago Capital LLC boosted its stake in GE HealthCare Technologies by 2.8% during the 3rd quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock valued at $414,000 after purchasing an additional 163 shares during the period. Chilton Capital Management LLC boosted its holdings in GE HealthCare Technologies by 15.4% in the 4th quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock valued at $95,000 after purchasing an additional 164 shares during the period. Procyon Advisors LLC grew its position in GE HealthCare Technologies by 5.2% in the 4th quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock worth $275,000 after purchasing an additional 175 shares during the last quarter. Meeder Advisory Services Inc. increased its holdings in shares of GE HealthCare Technologies by 5.4% during the 4th quarter. Meeder Advisory Services Inc. now owns 3,634 shares of the company’s stock worth $281,000 after purchasing an additional 185 shares during the period. Finally, Forum Financial Management LP raised its holdings in GE HealthCare Technologies by 3.9% in the 3rd quarter. Forum Financial Management LP now owns 4,989 shares of the company’s stock valued at $339,000 after acquiring an additional 186 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Up 0.3 %

Shares of GE HealthCare Technologies stock traded up $0.29 during trading on Friday, hitting $86.24. 1,790,695 shares of the company were exchanged, compared to its average volume of 3,297,646. The firm has a market capitalization of $39.35 billion, a P/E ratio of 28.56, a price-to-earnings-growth ratio of 3.02 and a beta of 0.94. The firm’s fifty day moving average price is $88.92 and its 200 day moving average price is $78.45. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.11. The company had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm’s revenue was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.31 EPS. As a group, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio is currently 3.97%.

Wall Street Analyst Weigh In

A number of research analysts have commented on GEHC shares. Evercore ISI raised their price target on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. HSBC started coverage on shares of GE HealthCare Technologies in a report on Thursday, February 15th. They set a “buy” rating and a $100.00 price target for the company. Citigroup lifted their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and increased their price target for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Finally, Mizuho boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, April 11th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus price target of $95.09.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.